Methyl 4-fluoro-2-methylbenzoate CAS:174403-69-1: Your Trusted Supplier for High-Purity Chemical Intermediates

Discover the essential role of Methyl 4-fluoro-2-methylbenzoate (CAS:174403-69-1) in advanced chemical synthesis. As a premier manufacturer and supplier in China, we provide high-purity intermediates vital for pharmaceutical development and research. Explore our reliable sourcing solutions and competitive pricing for your critical projects.

Get a Quote & Sample

Why Choose Our Methyl 4-fluoro-2-methylbenzoate?

Reliable Sourcing from China Manufacturers

Access a consistent and high-quality supply of Methyl 4-fluoro-2-methylbenzoate from our established network of Chinese manufacturers. We ensure product integrity and availability for your production needs.

Exceptional Purity for Research and Development

With a purity of 97%, our Methyl 4-fluoro-2-methylbenzoate is an ideal choice for complex organic synthesis and pharmaceutical R&D, where precision and reliability are paramount.

Efficient Supply Chain and Competitive Pricing

Benefit from our streamlined logistics and competitive pricing for Methyl 4-fluoro-2-methylbenzoate. We aim to provide cost-effective solutions without compromising on product quality or service.

Key Applications of Methyl 4-fluoro-2-methylbenzoate

Pharmaceutical Synthesis

Methyl 4-fluoro-2-methylbenzoate serves as a vital building block in the synthesis of various active pharmaceutical ingredients (APIs), contributing to the development of novel therapeutics.

Organic Synthesis

Its unique chemical structure makes it a versatile intermediate for a wide range of organic synthesis reactions, enabling the creation of complex molecules.

Research & Development

Crucial for exploratory research and the development of new chemical entities, providing R&D scientists with a reliable intermediate for their experiments.

Drug Discovery and Development

As a key component in early-stage drug discovery, this intermediate supports the synthesis of candidate molecules for preclinical and clinical trials.